Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
cancer
2
×
life sciences
merck
national blog main
new york blog main
raleigh-durham blog main
san diego blog main
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
10x genomics
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alnylam pharmaceuticals
alopecia areata
amarin
amgen
aridis pharmaceuticals
aristea therapeutics
astellas pharma
autoimmune diseases
axitinib
becton dickinson
bellus health
biotech ipos
bolt biotherapeutics
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bridgebio
bristol-myers squibb
cancer diagnostics
cell therapy
What
physicians
2
×
adding
advantages
aims
bar
bio
brings
company
deal
decisions
diagnostic
diagnostics
drug
expand
expect
fold
gamble
help
make
market
medco’s
mover
nanostring
new
patients
payers
plan
pricing
reach
roundup
sets
technology
tests
treatment
type
ubiome
undone
veracyte
vertex’s
Language
unset
Current search:
physicians
×
cancer
×
@xconomy.com
4 years ago
Veracyte Aims to Expand Diagnostics Reach With $50M NanoString Deal
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
